Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTpximpact Hldg Regulatory News (TPX)

Share Price Information for Tpximpact Hldg (TPX)

Share Price is delayed by 15 minutes
Get Live Data
67.50    1.00 (1.45%)
Bid:
66.00
Ask:
69.00
Spread: 3.00 (4.545%)
Market Cap: £66.34m
TPX Live PriceLast checked at - London Stock Exchange

Intraday Tpximpact Hldg Share Chart

Issue of Equity & Total Voting Rights

9 Dec 2019 17:05

RNS Number : 2666W
Panoply Holdings PLC (The)
09 December 2019
 

09 December 2019

 

The Panoply Holdings PLC

("The Panoply" or the "Company")

 

Issue of Earnout Shares and Total Voting Rights

 

The Panoply Holdings PLC, a digitally native technology services company, announces the admission of 291,065 new ordinary shares (the "Earnout Shares") to trading on the AIM market of the London Stock Exchange ("Admission"). The Earnout Shares represent the first of four tranches of further consideration payable in respect of the acquisition of Deeson Group Holdings Limited, totalling £0.96m. The Earnout Shares are being issued at 82.5p. Further details in relation to the Earnout Shares are contained in the Company's interim accounts, announced earlier today.

 

Application has been made to the London Stock Exchange for the 291,065 new Ordinary Shares to be admitted to trading on AIM ("Admission") and dealings are expected to commence on or around 8.00 a.m. 13 December 2019. The new Ordinary Shares will rank pari passu with the Company's existing Ordinary Shares.

Following admission, the total number of Ordinary Shares in issue will be 49,198,609. There are no Ordinary Shares held in treasury. The total number of voting rights in the Company is therefore 49,198,609. This number may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries:

 

The Panoply Holdings

Neal Gandhi (CEO)

Oliver Rigby (CFO)

 

Stifel Nicolaus Europe Limited (Nomad and Broker)

 

Via Alma PR

 

 

+44 (0) 207 710 7600

 

Fred Walsh

Alex Price

Neil Shah

Luisa Orsini Baroni

 

 

 

 

Alma PR (Financial PR)

panoply@almapr.co.uk

+44(0) 203 405 0206

 

Josh Royston

Rebecca Sanders-Hewett

Susie Hudson

 

+44 (0) 778 090 1979

 

About The Panoply

The Panoply is a digitally native technology services company, built to service clients' digital transformation needs. Founded in 2016, with the aim of identifying and acquiring best-of-breed specialist information technology, design and innovation consulting businesses across Europe, the Group collaborates with its clients to deliver the technology outcomes they're looking for at the pace that they expect and demand.

www.thepanoply.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEGMMGZNLFGLZM
Date   Source Headline
16th Jun 20267:00 amRNSUnaudited preliminary results
11th Jun 20267:00 amRNSShare Incentive Plan
1st Jun 20267:00 amRNSTPXimpact announces £16m contract with the MoJ
11th May 20267:00 amRNSShare Incentive Plan
22nd Apr 20267:00 amRNSFull Year Trading Update and Notice of Results
17th Apr 20264:17 pmRNSNotification of Major Holdings
17th Apr 20267:00 amRNSShare Incentive Plan
20th Mar 20267:00 amRNSShare Incentive Plan
24th Feb 20267:00 amRNSQ3 Trading Update: EBITDA guidance Upgrade
17th Feb 20267:00 amRNSContract Uplift
12th Feb 20267:01 amRNSTPXimpact announces £39m Contract with DEFRA
12th Feb 20267:00 amRNSShare Incentive Plan
11th Feb 20267:00 amRNSTPXimpact announces £22m NHS England contract
9th Jan 20267:00 amRNSShare Incentive Plan
9th Dec 20257:00 amRNSShare Incentive Plan
8th Dec 20255:19 pmRNSHolding(s) in Company
2nd Dec 20252:45 pmRNSExercise of Options, PDMR, & Total Voting Rights
2nd Dec 20257:00 amRNSUnaudited Interim Results
24th Nov 20257:30 amRNSAppointment of Nominated Adviser and Broker
14th Nov 20257:00 amRNSShare Incentive Plan
5th Nov 20257:00 amRNSFirst Half Update & Notice of Results
14th Oct 20255:29 pmRNSShare Incentive Plan
25th Sep 20254:37 pmRNSResult of AGM
9th Sep 20257:00 amRNSShare Incentive Plan
8th Sep 20255:25 pmRNSExercise of Options & PDMR Dealings
8th Sep 20253:27 pmRNSNotification of Major Holdings
5th Sep 202512:37 pmRNSIssuance of Shares & Total Voting Rights
22nd Aug 20257:00 amRNSNotice of AGM
21st Aug 20257:00 amRNSChange of Auditor
12th Aug 20256:05 pmRNSReplacement: FY25 & FY26 Share Awards
11th Aug 20257:00 amRNSPosting of Annual Report
4th Aug 20259:24 amRNSReplacement: FY25 & FY26 Share Awards
4th Aug 20257:00 amRNSFY25 & FY26 Long-Term Incentive Share Award
30th Jul 20257:00 amRNSDebt Facility Renewal Update
14th Jul 20257:00 amRNSAppointment of non-executive director
10th Jul 20257:00 amRNSShare Incentive Plan
24th Jun 20257:00 amRNSUnaudited preliminary results
16th Jun 20259:00 amRNSNotice of Results
12th Jun 20251:17 pmRNSShare Incentive Plan
14th May 20257:00 amRNSTrading Update and Contract Wins
22nd Apr 20257:00 amRNSResignation of Non-Executive Director
11th Apr 20257:00 amRNSShare Incentive Plan
12th Mar 20257:00 amRNSShare Incentive Plan
28th Feb 20253:26 pmRNSChange of Registered Office Address
12th Feb 20257:00 amRNSShare Incentive Plan
6th Feb 20257:00 amRNSQ3 Trading Update and Revised Outlook
3rd Feb 20257:00 amRNSConfirmation of CFO Appointment
15th Jan 20257:00 amRNSShare Incentive Plan
18th Dec 20247:00 amRNSDirectorate Change - Group CFO retirement
11th Dec 20247:00 amRNSShare Incentive Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.